Effects of environmental hypoxia on cardiac energy metabolism and performance in tilapia.
The ability of an animal to depress ATP turnover while maintaining metabolic energy balance is important for survival during hypoxia. In the present study, we investigated the responses of cardiac energy metabolism and performance in the hypoxia-tolerant tilapia (Oreochromis hybrid sp.) during exposure to environmental hypoxia. Exposure to graded hypoxia (> or =92% to 2.5% air saturation over 3.6 +/- 0.2 h) followed by exposure to 5% air saturation for 8 h caused a depression of whole animal oxygen consumption rate that was accompanied by parallel decreases in heart rate, cardiac output, and cardiac power output (CPO, analogous to ATP demand of the heart). These cardiac parameters remained depressed by 50-60% compared with normoxic values throughout the 8-h exposure. During a 24-h exposure to 5% air saturation, cardiac ATP concentration was unchanged compared with normoxia and anaerobic glycolysis contributed to ATP supply as evidenced by considerable accumulation of lactate in the heart and plasma. Reductions in the provision of aerobic substrates were apparent from a large and rapid (in <1 h) decrease in plasma nonesterified fatty acids concentration and a modest decrease in activity of pyruvate dehydrogenase. Depression of cardiac ATP demand via bradycardia and an associated decrease in CPO appears to be an integral component of hypoxia-induced metabolic rate depression in tilapia and likely contributes to hypoxic survival.
Speers-Roesch
Ben
B
Dept. of Zoology, Univ. of British Columbia, 6270 Univ. Blvd., Vancouver, BC, Canada V6T 1Z4. bensr@zoology.ubc.ca
Sandblom
Erik
E
Lau
Gigi Y
GY
Farrell
Anthony P
AP
Richards
Jeffrey G
JG
D000091162:AMP-Activated Protein Kinase Kinases; D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D002302:Cardiac Output / Q000502:physiology*; D004734:Energy Metabolism / Q000502:physiology*; D005230:Fatty Acids, Nonesterified / Q000378:metabolism; D029941:Fish Proteins / Q000378:metabolism; D006339:Heart Rate / Q000502:physiology*; D000860:Hypoxia / Q000378:metabolism / Q000503:physiopathology*; D007773:Lactates / Q000378:metabolism; D008297:Male; D023421:Models, Animal; D009206:Myocardium / Q000378:metabolism*; D047493:PPAR alpha / Q000378:metabolism; D020648:Peptide Elongation Factor 1 / Q000378:metabolism; D011494:Protein Kinases / Q000378:metabolism; D017210:Tilapia / Q000502:physiology*; D013997:Time Factors
D005230:Fatty Acids, Nonesterified; D029941:Fish Proteins; D007773:Lactates; D047493:PPAR alpha; D020648:Peptide Elongation Factor 1; D000255:Adenosine Triphosphate; D011494:Protein Kinases; D000091162:AMP-Activated Protein Kinase Kinases